Catalyst Pharmaceuticals (CPRX) Goodwill & Intangibles (2022 - 2026)

Catalyst Pharmaceuticals (CPRX) has 5 years of Goodwill & Intangibles data on file, last reported at $240.2 million in Q1 2026.

• Quarterly Goodwill & Intangibles rose 63.05% year-over-year to $240.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $240.2 million (up 63.05% YoY) and the FY2025 annual result came in at $240.2 million, up 53.32% from the prior year.
• Goodwill & Intangibles held at $240.2 million in Q1 2026, from $240.2 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $240.2 million in Q4 2025 to a low of $32.5 million in Q4 2022.
• A 5-year average of $166.4 million and a median of $175.4 million in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2023 — Goodwill & Intangibles jumped 601.28% — and 2024, when it plunged 31.2%.
• Tracing CPRX's Goodwill & Intangibles over 5 years: stood at $32.5 million in 2022, then jumped by 601.28% to $227.7 million in 2023, then slumped by 31.2% to $156.7 million in 2024, then surged by 53.32% to $240.2 million in 2025, then changed by 0.0% to $240.2 million in 2026.
• The last three Goodwill & Intangibles figures came in at $240.2 million (Q1 2026), $240.2 million (Q4 2025), and $227.7 million (Q3 2025), per Business Quant data.